Season 1 – The Marketing AI SparkCast
In this episode of The Marketing AI SparkCast, Aby Varma, founder of Spark Novus, sits down with Piyush Saggi, co-founder and CEO of Parmonic, to discuss AI’s impact on video storytelling. They explore AI’s role in video transformation, storytelling challenges, and how brands can balance automation with authenticity. Topics Covered * The Rise of…
Latest
Business Services
Marketing AI Adoption in B2B Enterprises
Aby Varma, founder of Spark Novus, leads a discussion on how AI is reshaping marketing within large B2B enterprises. He speaks with Shonodeep Modak, CMO of Schneider Electric’s Energy Management Business, about their AI journey, operational challenges, and strategies for successful AI adoption in marketing. They highlight lessons learned, misconceptions, and the future of…
Business Services
Adopting AI is Not a Marketing Strategy
In this episode of Marketing AI SparkCast, host Aby Varma, the founder of Spark Novus, a firm that partners with marketing leaders to adopt AI responsibly and strategically discusses the nuances of AI integration with marketing and content expert Rob Rose. Together, they explore that AI adoption is not a standalone strategy but technology…
Business Services
Navigating the AI Wave in Event Technology
In this episode of The Marketing AI SparkCast, Aby Varma, host, and founder of Spark Novus, discusses how AI is transforming the event planning industry. Joined by Michael Sorensen, Director of Product Management at Cvent, the conversation delves into how AI enhances both attendee experiences and event planner efficiencies in managing large-scale events. Topics…
Business Services
The Future of Brand-Agency Dynamic in the Age of AI
Hosted by Aby Varma, founder of Spark Novus, this episode of The Marketing AI SparkCast features David DeWolf, CEO of Knownwell. They discuss how AI reshapes brand-agency relationships, blending human creativity with AI’s efficiency to manage agency collaborations. In this episode of The Marketing AI SparkCast, Aby Varma, founder of Spark Novus—a company that…
Articles
How to Champion AI in Marketing
In this episode of the Marketing AI SparkCast, Aby Varma, founder of Spark Novus, sits down with guest Jessica Hreha, Head of Marketing AI Strategy and Transformation at Jasper. The conversation delves into Jessica’s inspiring journey from her time at VMware to her leadership role at Jasper, where she fosters AI adoption across enterprises….
Articles
Practical Tips for Adopting AI in Marketing
In this episode of the Marketing AI SparkCast, Aby Varma, founder of Spark Novus, hosts Ruth Favela, the AI Marketing Manager at Tomorrow.io. They explore the transformative impact of AI on marketing, focusing on practical applications and strategies for marketers. Topics Covered: · Ruth’s Journey in AI Marketing: Ruth shares her transition from…
Latest
Analyzing the Suppressive TME in In Vitro Based Assays
In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…
Targeting T Cells Within the Cancer Immunity Cycle
As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…
Inside Oncology Drug Development: Overcoming Resistance with Science
In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…
